Nothing Special   »   [go: up one dir, main page]

JP2005143677A - Medical fluid container equipped with communication means - Google Patents

Medical fluid container equipped with communication means Download PDF

Info

Publication number
JP2005143677A
JP2005143677A JP2003383224A JP2003383224A JP2005143677A JP 2005143677 A JP2005143677 A JP 2005143677A JP 2003383224 A JP2003383224 A JP 2003383224A JP 2003383224 A JP2003383224 A JP 2003383224A JP 2005143677 A JP2005143677 A JP 2005143677A
Authority
JP
Japan
Prior art keywords
male luer
communication means
chemical
container
chemical solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003383224A
Other languages
Japanese (ja)
Other versions
JP2005143677A5 (en
Inventor
Teruhisa Hirobe
輝久 広部
Akifumi Aramata
章文 荒俣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP2003383224A priority Critical patent/JP2005143677A/en
Publication of JP2005143677A publication Critical patent/JP2005143677A/en
Publication of JP2005143677A5 publication Critical patent/JP2005143677A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068Venting means
    • A61J1/2075Venting means for external venting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00General characteristics or adaptations
    • A61J2200/10Coring prevention means, e.g. for plug or septum piecing members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/1782Devices aiding filling of syringes in situ

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a medical fluid container equipped with a communication means with which a preparation operation of the medical fluid can be performed easily and quickly without a risk of an injury of an operator or generation of coring. <P>SOLUTION: The medical fluid container 10 which has a male lure 11 to connect to a needle at a pointed head, and the communication means 20 which is attached to the pointed head of the medical fluid container 10 and includes a cylindrical guide section 21 with a bottom which can be removably attached by a vial aperture section and a hollow puncture member 23 which is disposed at the center part of the bottom 22 of the guide section 21 to penetrate the bottom 22 are connected by screwing of a female screw 26 at the inside of a connection section 25 of the puncturing member 23 at a distal end side than the bottom 22 and a male screw 12 at the outside of the basal part of the male lure 11. Also, a residue section 28 is connected to the connection section 25 at more distal end side than the female screw 26 through a break section 27 and the residue section 28 is engaged to a flange 13 which is formed at a basal part of the male lure 11 so that he break section 27 is broken when the screwing of the connection section 25 and the male lure 11 is released. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、内部に予め薬液を充填してなる連通手段付き薬液容器に関する。更に詳しくは、バイアル口部の封止部材を穿刺する穿刺針とバイアルガイドを含んでなる連通手段を剥離可能に接続した、内部に予め薬液を充填してなる連通手段付き薬液容器に関する。   The present invention relates to a chemical solution container with communication means in which a chemical solution is filled in advance. More specifically, the present invention relates to a chemical solution container with communication means in which a communication means including a puncture needle that punctures a sealing member at a vial mouth and a vial guide is releasably connected and is filled with a chemical solution in advance.

液剤とした場合に製剤的、薬効的な安定性を保つことの困難な薬品は、従来、固形製剤や粉末製剤、凍結乾燥製剤としてバイアルなどに収容して保存しておき、用時にシリンジなどを用いて溶解液と混合し、液剤に調製して使用している。   Drugs that are difficult to maintain pharmaceutical and medicinal stability when used as liquids have been stored in vials as solid preparations, powder preparations, and lyophilized preparations. It is used by mixing with the solution and preparing it as a liquid.

例えば、バイアルに収容された固形製剤の場合、バイアルやアンプルに収容された溶解液をシリンジに吸引し(又は、予め溶解液の充填された所謂プレフィルドシリンジに溶解液注入針を装着し)、注入針をバイアルのゴム栓に刺通して、シリンジからバイアル内に溶解液を注入し、固形製剤を溶解液と混合して薬液に調製し、薬液調製操作終了後、薬液をバイアルからシリンジに再吸引していた。   For example, in the case of a solid preparation contained in a vial, the solution contained in the vial or ampoule is sucked into a syringe (or a solution injection needle is attached to a so-called prefilled syringe pre-filled with a solution) for injection. The needle is pierced through the rubber stopper of the vial, the solution is injected from the syringe into the vial, the solid preparation is mixed with the solution to prepare the drug solution, and after the drug solution preparation operation is completed, the drug solution is re-aspirated from the vial into the syringe. It was.

しかし、このシリンジを用いる方法では薬液調製操作に金属針を必要としているため、操作者が注射針で怪我をしたり、バイアルのゴム栓に針を斜めに刺した場合などにゴム栓のコアリングが生じたりする虞があった。また、何よりその操作が煩雑であるため、その調製に少なからず時間がかかっていた。   However, since this method using a syringe requires a metal needle for the preparation of the chemical solution, the coring of the rubber stopper is necessary when the operator is injured by the injection needle or when the needle is inserted into the rubber stopper of the vial at an angle. May occur. Moreover, since the operation was complicated above all, it took time to prepare.

そこで、前記したような問題を解決すべく前後2つのラバーストッパーにより液密に封止されたプレフィルドシリンジの注射針接続部に穿刺針部材の装着部を嵌合してなる発明がある。この発明によると、粉末製剤等が充填されているバイアルに対しプレフィルドシリンジから溶解液等を容易且つ確実に注入することができると共に、一般の注射針(金属針)を用いないのでゴム栓の細片を含む薬液を患者の体内に注射するおそれがなくなるとある(特許文献1参照)。   Therefore, there is an invention in which a mounting portion of a puncture needle member is fitted to an injection needle connecting portion of a prefilled syringe sealed in a liquid-tight manner by two front and rear rubber toppers in order to solve the above-described problem. According to the present invention, it is possible to easily and surely inject a solution from a prefilled syringe into a vial filled with a powder preparation or the like, and since a general injection needle (metal needle) is not used, the rubber stopper is thin. There is no risk of injecting a drug solution containing a piece into a patient's body (see Patent Document 1).

特開2002−78798号JP 2002-78798 A

また、注射針接続部の先端に容易に破断可能な穿刺針を備えたバレルと、このバレルに挿着されたガスケットと、バレルの先端から挿着されたガイド手段を含んでなり、このガイド手段をバレルに対して相対的に回転させた時に、穿刺針が注射針接続部から破断されるようにした発明もなされている。この発明によると、操作者が怪我をしたり、コアリングを発生したりすることなく薬液調製操作を行うことの出来るとある(特許文献2参照)。   Further, the guide means comprises a barrel provided with a puncture needle that can be easily broken at the tip of the injection needle connection portion, a gasket inserted into the barrel, and guide means inserted from the tip of the barrel. There is also an invention in which the puncture needle is broken from the injection needle connecting portion when the needle is rotated relative to the barrel. According to the present invention, there is a case where an operator can perform a chemical solution preparation operation without causing injury or causing coring (see Patent Document 2).

特開2003−190286号公報JP 2003-190286 A

しかしながら特許文献1記載の発明では、穿刺部材と注射針接続部とが装着部の螺合のみによって接続されているため、前部ラバーストッパーを用いずにシリンジ内部に薬液を充填し高圧蒸気滅菌を行った場合、この接続部より薬液が漏出する虞がある。この問題を防止するため前部ラバーストッパーによりシリンジ内の薬液を密封しているが、使用時に前部ラバーストッパーの外壁面にバイパスを形成する筒先部材も必要となるなどシリンジの構造が複雑となり、製造工程も煩雑となる。また、ラバーストッパーの素材となるゴム部材は高価であるため製造コストも高くなる。さらに、バイアルガイドが設けられていないため、バイアル口部の封止部材への穿刺がしずらく、ゴム栓に対して穿刺部材を斜めに穿刺した場合コアリングが発生し易く、穿刺部材の先端が手指等に触れ汚染されるおそれがある。   However, in the invention described in Patent Document 1, since the puncture member and the injection needle connecting part are connected only by screwing of the mounting part, the syringe is filled with a chemical solution without using the front rubber stopper, and high-pressure steam sterilization is performed. If it is performed, there is a possibility that the chemical solution leaks from this connecting portion. In order to prevent this problem, the medical solution in the syringe is sealed by the front rubber stopper, but the syringe structure becomes complicated, such as the need to form a tube tip member that forms a bypass on the outer wall surface of the front rubber stopper when used, The manufacturing process is also complicated. Moreover, since the rubber member used as the material of the rubber topper is expensive, the manufacturing cost is also increased. Furthermore, since the vial guide is not provided, it is difficult to puncture the sealing member of the vial mouth, and coring is likely to occur when the puncture member is punctured obliquely with respect to the rubber stopper, and the tip of the puncture member May touch your fingers and become contaminated.

また特許文献2記載の発明では、ガイド手段を回転させ穿刺針を注射針接続部から破断した際に微粒子が発生し、この微粒子が薬液に混入するおそれが皆無ではない。   In the invention described in Patent Document 2, fine particles are generated when the guide means is rotated and the puncture needle is broken from the injection needle connecting portion, and there is no possibility that the fine particles are mixed into the drug solution.

そこで、本発明者らは前記した課題を解決すべく鋭意研究を重ねた結果、本発明に想到した。すなわち本発明は、
(1) 注射針を接続可能なオスルアーを先端に有する薬液容器と、前記オスルアーの先端に設けられた中空の連通手段を含み、該連通手段は、バイアルの口部をスライド自在に挿着可能な有底筒状のガイド部と、該ガイド部の底面中央部に該底面を貫通して設けられた中空の穿刺部材を含み、該穿刺部材は、底面より先端側の穿刺針と底面より基端側の接続部を有し、該接続部が前記オスルアーに螺合により接続されてなる連通手段付き薬液容器であって、
前記接続部のメネジよりも基端側に、破断部を介して残留部が連接され、前記残留部が前記オスルアー基部のフランジに係合され、前記接続部と前記オスルアーの螺合の解除時に前記破断部が破断する薬液容器;
(2) 先端にオスルアーを有する薬液容器と、前記オスルアーの先端に設けられた中空の連通手段を含み、該連通手段は、バイアルの口部をスライド自在に挿着可能な有底筒状のガイド部と、該ガイド部の底面中央部に該底面を貫通して設けられた中空の穿刺部材を含み、該穿刺部材は、底面より先端側の穿刺針と底面より基端側の接続部を有し、該接続部が前記オスルアーに係合により接続されてなる連通手段付き薬液容器であって、
前記接続部の基部に破断部を介して残留部が連接され、前記残留部が前記オスルアー基部のフランジに係合されることで前記接続部が前記オスルアーに接続され、前記接続部と前記オスルアーの分離時に前記破断部が破断する薬液容器;
(3) 前記ガイド部の底面とオスルアーの先端面との間に、同心円状のパッキンを介装してなる前記(1)又は(2)に記載の薬液容器;
(4) 前記薬液容器が、先端にオスルアーを有する基端の開放されたバレルと、該バレルの基端からバレル内に液密かつ摺動可能に挿着されたガスケットからなるシリンジである前記(1)〜(3)の何れかに記載の薬液容器;
(5) 前記薬液容器が、先端にオスルアーを有する、押圧により容易に変形可能なボトルである前記(1)〜(3)の何れかに記載の薬液容器;
(6) 内部に予め薬液が充填されてなる前記(1)〜(5)の何れかに記載の薬液容器;等に関する。
Thus, the present inventors have intensively studied to solve the above-mentioned problems, and have arrived at the present invention. That is, the present invention
(1) It includes a drug solution container having a male luer at the tip thereof to which an injection needle can be connected, and a hollow communication means provided at the tip of the male luer, which can be slidably inserted into the mouth of the vial. A bottomed cylindrical guide portion and a hollow puncture member provided at the center of the bottom surface of the guide portion so as to penetrate the bottom surface, the puncture member including a puncture needle on the distal end side from the bottom surface and a proximal end from the bottom surface A chemical container with communication means having a connecting portion on the side, the connecting portion being connected to the male luer by screwing,
A residual portion is connected to the base end side of the female screw of the connection portion via a fracture portion, the residual portion is engaged with a flange of the male luer base portion, and when the screwing of the connection portion and the male luer is released, A chemical container in which the fracture part breaks;
(2) A bottomed cylindrical guide that includes a chemical container having a male luer at the tip and a hollow communication means provided at the tip of the male luer, the slidable insertion of the mouth of the vial. And a hollow puncture member provided through the bottom surface at the center of the bottom surface of the guide portion, the puncture member having a puncture needle on the distal end side from the bottom surface and a connection portion on the proximal end side from the bottom surface. And the connecting part is a chemical solution container with communication means formed by engagement with the male luer,
The residual portion is connected to the base portion of the connection portion via a fracture portion, and the connection portion is connected to the male luer by engaging the residual portion with a flange of the male luer base portion. A chemical container in which the rupture portion breaks during separation;
(3) The chemical solution container according to (1) or (2), wherein a concentric packing is interposed between a bottom surface of the guide portion and a tip surface of the male luer;
(4) The chemical liquid container is a syringe including a barrel having a male luer at the distal end and an open base end, and a gasket that is liquid-tightly and slidably inserted into the barrel from the base end of the barrel. 1) A chemical container according to any one of (3);
(5) The chemical solution container according to any one of (1) to (3), wherein the chemical solution container is a bottle that has a male luer at a tip and can be easily deformed by pressing;
(6) The chemical solution container according to any one of (1) to (5), which is filled with a chemical solution in advance.

本発明によれば、操作者が怪我をしたりコアリングを発生したりすることなく、簡便に短時間で薬液調製作業を行うことが出来る連通手段付き薬液容器を提供することができる。また、金属針を使用していないので金属針とプラスチック製部材を分別する労を省くことができる。   ADVANTAGE OF THE INVENTION According to this invention, the chemical | medical solution container with a communication means which can perform a chemical | medical solution preparation operation | work simply and in a short time without an operator being injured or generating a coring can be provided. Further, since no metal needle is used, labor for separating the metal needle and the plastic member can be saved.

次に、本発明の実施例を図面に基づいて説明する。
図1は実施例1の縦断面図であり、薬液容器としてシリンジを採用している。なお、薬液容器と連通手段とは螺合により接続されている。
図2は実施例1の拡大縦断面図である。
図3は実施例1の拡大正面図である。
図4は実施例1の拡大正面図であり、連通手段が残留部を残して取り去られた状態を示している。
図5は実施例2の拡大断面図であり、オスルアー基部のフランジは別部材により形成されている。
図6は実施例3の拡大断面図であり、薬液容器と連通手段とは係合により接続されている。
図7は実施例4の拡大断面図であり、オスルアー基部のフランジは別部材により形成されている。
図8は実施例5の縦断面図であり、薬液容器としてボトルを採用している。
図9は本発明の使用時の状態を示す縦断面図であり、実施例1の連通手段付き薬液容器にバイアルを挿着している。
Next, embodiments of the present invention will be described with reference to the drawings.
FIG. 1 is a longitudinal sectional view of Example 1, and a syringe is employed as a chemical solution container. The chemical solution container and the communication means are connected by screwing.
FIG. 2 is an enlarged longitudinal sectional view of the first embodiment.
FIG. 3 is an enlarged front view of the first embodiment.
FIG. 4 is an enlarged front view of the first embodiment, showing a state in which the communication means is removed leaving a residual portion.
FIG. 5 is an enlarged cross-sectional view of the second embodiment, and the flange of the male luer base is formed of a separate member.
FIG. 6 is an enlarged cross-sectional view of Example 3, in which the chemical solution container and the communication means are connected by engagement.
FIG. 7 is an enlarged cross-sectional view of Example 4, and the flange of the male luer base is formed of a separate member.
FIG. 8 is a vertical cross-sectional view of Example 5, and employs a bottle as a chemical solution container.
FIG. 9 is a longitudinal sectional view showing the state of use of the present invention.

本発明の実施例1を図1〜4を用いて説明する。図1に示す連通手段付き薬液容器1は、注射針を接続可能なオスルアー11を先端に有する薬液容器10と、この薬液容器10の先端に設けられた中空の連通手段20を含み、この連通手段20は、バイアル口部をスライド自在に挿着可能な、有底筒状のガイド部21と、このガイド部21の底面22中央部にこの底面22を貫通して設けられた中空の穿刺部材23を含んでいる。この穿刺部材23は、底面22より先端側の穿刺針24と、底面22より基端側の接続部25を有しており、接続部25の基部の内側のメネジ26が、オスルアー11の基部の外側のオネジ12と螺合することにより接続される。そして、接続部25のメネジ26よりもさらに基端側には、破断部27を介して残留部28が連接され、この残留部28がオスルアー11の基部に形成されたフランジ13に係合されており、接続部25とオスルアー11の螺合の解除時に破断部27が破断する。   A first embodiment of the present invention will be described with reference to FIGS. A chemical solution container 1 with communication means shown in FIG. 1 includes a chemical solution container 10 having a male luer 11 to which a syringe needle can be connected at the tip, and a hollow communication means 20 provided at the tip of the drug solution container 10. Reference numeral 20 denotes a bottomed cylindrical guide portion 21 into which a vial mouth portion can be slidably inserted, and a hollow puncture member 23 provided through the bottom surface 22 at the center of the bottom surface 22 of the guide portion 21. Is included. The puncture member 23 has a puncture needle 24 on the distal end side with respect to the bottom surface 22 and a connection portion 25 on the proximal end side with respect to the bottom surface 22, and a female screw 26 inside the base portion of the connection portion 25 is attached to the base portion of the male luer 11. Connection is established by screwing with the external male screw 12. Further, a residual portion 28 is connected to the base end side of the connecting portion 25 further than the female screw 26 via a fracture portion 27, and this residual portion 28 is engaged with the flange 13 formed at the base portion of the male luer 11. In addition, the breaking portion 27 is broken when the connection portion 25 and the male luer 11 are unscrewed.

接続部25の内面はオスルアー11と液密に嵌合するメスルアーに形成されてもよいが、図1及び2に示すようにオスルアー11の外面との間に隙間が形成されていてもよい。ただしその場合には、ガイド部21の底面22とオスルアー11の先端面14との間に同心円状のパッキン30を介装しておくことが好ましい。これにより、本発明に係る連通手段付き薬液容器を高圧蒸気滅菌した際、オスルアー11と接続部25の隙間から容器内部への水分の侵入を防止したり、反対に容器内部からの薬液Sの漏出を防止したりできる。パッキン30としては、例えばOリングや角リングが挙げられるが、底面22とオスルアー11の先端面14との隙間を液密且つ薬液容器10と穿刺針24とを連通した状態で保持可能ならばその形状は特に限定されない。またパッキン30の材質としては、ブチルゴム、シリコンゴム、熱可塑性エラストマー、シリコンエラストマー等の弾性材料が挙げられるが、医療用材料としての使用実績があり、内部に収容される薬液Sと相互作用せず、薬液Sへの溶出等のおそれのない材料であればいずれも好適に採用可能である。なお、前記したようにオスルアーと接続部が液密に当接したり、メネジ26とオネジ12が液密に接続されたりするならば、パッキン30を設けるには及ばない。   The inner surface of the connecting portion 25 may be formed as a female luer that fits the male luer 11 in a liquid-tight manner, but a gap may be formed between the outer surface of the male luer 11 as shown in FIGS. However, in that case, it is preferable that a concentric packing 30 be interposed between the bottom surface 22 of the guide portion 21 and the tip surface 14 of the male luer 11. Thus, when the chemical container with the communication means according to the present invention is sterilized by high-pressure steam, the intrusion of moisture into the container through the gap between the male luer 11 and the connection portion 25 is prevented, or the chemical liquid S leaks from the container inside. Can be prevented. Examples of the packing 30 include an O-ring and a square ring. If the gap between the bottom surface 22 and the tip surface 14 of the male luer 11 is liquid-tight and the drug solution container 10 and the puncture needle 24 can be held in communication with each other, The shape is not particularly limited. Examples of the material of the packing 30 include elastic materials such as butyl rubber, silicone rubber, thermoplastic elastomer, silicone elastomer, etc., but they have been used as medical materials and do not interact with the chemical S contained therein. Any material can be suitably used as long as it does not have a risk of elution into the chemical solution S. As described above, if the male luer and the connection portion are in liquid-tight contact, or if the female screw 26 and the male screw 12 are connected in a liquid-tight manner, it is not necessary to provide the packing 30.

ここで、薬液容器10としては、先端にオスルアー11を有する基端の開放された略円筒状のバレル15と、このバレル15の基端からバレル15内に液密かつ摺動自在に挿着されたガスケット40からなるシリンジ型の薬液容器となっている。バレル15の基端には指掛用のフランジ16が形成されている。バレル15の形成材料としては、ポリエチレン、ポリプロピレン、ポリエチレンとポリプロピレンの混合物、環状ポリオレフィン等のポリオレフィン樹脂が挙げられるが、ポリカーボネート、メタクリル樹脂、ポリメチルペンテン等、医療用材料としての使用実績があり、内部に収容される薬液Sと相互作用せず、薬液Sへの溶出等のおそれのない樹脂であればいずれも好適に採用可能である。   Here, as the chemical solution container 10, a substantially cylindrical barrel 15 having an open base end having a male luer 11 at the distal end, and a liquid tight and slidable insertion from the base end of the barrel 15 into the barrel 15. This is a syringe-type chemical solution container comprising the gasket 40. At the base end of the barrel 15, a finger hooking flange 16 is formed. Examples of the material for forming the barrel 15 include polyethylene, polypropylene, a mixture of polyethylene and polypropylene, and polyolefin resins such as cyclic polyolefin, but have been used as medical materials such as polycarbonate, methacrylic resin, and polymethylpentene. Any resin can be suitably used as long as it does not interact with the chemical solution S contained in the container and has no fear of elution into the chemical solution S.

ガスケット40の基端にはメネジ41等の結合手段が形成されており、ロッド50の先端に設けたオネジ51を結合することができるようになっている。ガスケット40の形成材料としては、ブチルゴム、シリコンゴム、熱可塑性エラストマー、シリコンエラストマー等の弾性材料が挙げられるが、医療用材料としての使用実績があり、内部に収容される薬液Sと相互作用せず、薬液Sへの溶出等のおそれのない材料であればいずれも好適に採用可能である。   A coupling means such as a female screw 41 is formed at the base end of the gasket 40 so that a male screw 51 provided at the tip of the rod 50 can be coupled. Examples of the material for forming the gasket 40 include elastic materials such as butyl rubber, silicone rubber, thermoplastic elastomer, and silicone elastomer. However, the gasket 40 has been used as a medical material and does not interact with the chemical S contained therein. Any material can be suitably used as long as it does not have a risk of elution into the chemical solution S.

ロッド50の先端にはオネジ51が形成されるとともに、基端にはシリンジ内の薬液Sを排出するときに指で押すための押圧板52が形成されている。ロッド50の形成材料としては、ポリエチレン、ポリプロピレン、ポリエチレンとポリプロピレンの混合物、環状ポリオレフィン等のポリオレフィン樹脂が最も好ましいが、ポリカーボネート、メタクリル樹脂、ポリメチルペンテン、ABS樹脂等、医療用材料として使用実績のあるものであれば特に限定されない。   A male screw 51 is formed at the distal end of the rod 50, and a pressing plate 52 is formed at the proximal end for pressing with a finger when the chemical solution S in the syringe is discharged. As a material for forming the rod 50, polyethylene resin, polypropylene, a mixture of polyethylene and polypropylene, and polyolefin resin such as cyclic polyolefin are most preferable, but polycarbonate, methacrylic resin, polymethylpentene, ABS resin, etc. have been used as medical materials. If it is a thing, it will not specifically limit.

連通手段20は、バイアル口部をスライド自在に挿着可能な有底筒状のガイド部21と、このガイド部21の底面22の中央部にこの底面22を貫通して設けられた中空の穿刺部材23を含んでなり、穿刺部材23は、底面22より先端側の穿刺針24と、底面より基端側の接続部25を有している。この接続部25は、薬液容器10のオスルアー11に外嵌するとともに、接続部25の基部の内側のメネジ26が、オスルアー11の基部の外側のオネジ12と螺合する。また、穿刺針24はキャップ60により液密又は気密に密封されている。キャップ60の形成材料としては、ブチルゴム、シリコンゴム、熱可塑性エラストマー、シリコンエラストマー等の弾性材料や、ポリエチレン、ポリプロピレン、ポリエチレンとポリプロピレンの混合物、環状ポリオレフィン、ポリカーボネート、メタクリル樹脂、ポリメチルペンテン等のプラスチック材料が挙げられるが、医療用材料としての使用実績があり、内部に収容される薬液Sと相互作用せず、薬液Sへの溶出等のおそれのない材料であればいずれも好適に採用可能である。   The communicating means 20 includes a bottomed cylindrical guide portion 21 into which a vial mouth portion can be slidably inserted, and a hollow puncture provided at the center of the bottom surface 22 of the guide portion 21 through the bottom surface 22. The puncture member 23 includes a member 23, and has a puncture needle 24 on the distal end side from the bottom surface 22 and a connecting portion 25 on the proximal end side from the bottom surface. The connecting portion 25 is externally fitted to the male luer 11 of the chemical solution container 10, and the female screw 26 inside the base portion of the connecting portion 25 is screwed with the male screw 12 outside the base portion of the male luer 11. The puncture needle 24 is sealed liquid-tight or air-tightly by a cap 60. As a material for forming the cap 60, elastic materials such as butyl rubber, silicon rubber, thermoplastic elastomer, and silicon elastomer, and plastic materials such as polyethylene, polypropylene, a mixture of polyethylene and polypropylene, cyclic polyolefin, polycarbonate, methacrylic resin, and polymethylpentene. However, any material that has been used as a medical material, does not interact with the chemical solution S contained therein, and has no fear of elution into the chemical solution S can be suitably used. .

薬液容器10のオスルアー11のオネジ12よりも基端側の基部には、図1及び2に示すように、周方向にわたって径方向外側に突出するフランジ13が一体に成形されている。また穿刺部材23の接続部25のメネジ26よりも基端側に、破断部27を介して残留部28が連接されている。この破断部27は、細い薄肉状とされて、周方向等間隔に配設されている。また、残留部28の一部又は周方向全長にわたる部分からは、爪部29が径方向内側に突設されていて、フランジ13の基端面に係合されている。これにより、連通手段20と薬液容器10の分離時、即ち穿刺部材23の接続部25と薬液容器10のオスルアー11の螺合が解除される際には、破断部27が破断されて、残留部28と爪部29がオスルアー11側に残ることになる。なお、爪部29の基端面は、径方向内側に向かうに従って、先端側に移行する傾斜状とされており、これにより接続部25をオスルアー11に結合した際に、爪部29が先端側からフランジ13を容易に乗り越えて、その基端面に係合される。なお、乗り越えるときには、残留部28及び爪部29等が径方向外側に弾性変形する。   As shown in FIGS. 1 and 2, a flange 13 projecting radially outward in the circumferential direction is integrally formed at the base portion of the male luer 11 of the chemical solution container 10 on the base end side of the male screw 12. Further, a residual portion 28 is connected to the base end side of the connecting portion 25 of the puncture member 23 via a fracture portion 27. The broken portions 27 are thin and thin, and are arranged at equal intervals in the circumferential direction. A claw portion 29 protrudes radially inward from a part of the remaining portion 28 or the entire length in the circumferential direction, and is engaged with the proximal end surface of the flange 13. As a result, when the communication means 20 and the chemical solution container 10 are separated, that is, when the connection portion 25 of the puncture member 23 and the male luer 11 of the chemical solution container 10 are released, the breaking portion 27 is broken and the remaining portion 28 and the claw portion 29 remain on the male luer 11 side. The base end surface of the claw portion 29 is inclined so as to move to the distal end side as it goes radially inward, so that when the connection portion 25 is coupled to the male luer 11, the claw portion 29 is moved from the distal end side. It easily gets over the flange 13 and is engaged with its proximal end face. In addition, when getting over, the residual part 28, the nail | claw part 29, etc. elastically deform radially outward.

実施例1の連通手段付き薬液容器1を使用する際には、図9に示すように、ガイド部21にバイアルVを接続した後、薬液容器10内の薬液SをバイアルV内に注入して、バイアルV内の薬剤D(例えば凍結乾燥製剤)と混合する。   When using the chemical solution container 1 with communication means of Example 1, as shown in FIG. 9, after the vial V is connected to the guide portion 21, the chemical solution S in the chemical solution container 10 is injected into the vial V. Mix with drug D (eg lyophilized formulation) in vial V.

次いで、本発明の実施例2を図5を用いて説明する。図5に示す実施例2は、実施例1の変形例で、フランジ113がオスルアー111とは別個に形成され、オスルアー111外面の周溝117に嵌合されている。これにより、フランジがオスルアーの基部に一体成形しにくい場合でも、フランジを設けることができる。フランジ113の形成材料としては、ポリエチレン、ポリプロピレン、ポリエチレンとポリプロピレンの混合物、環状ポリオレフィン等のポリオレフィン樹脂が最も好ましいが、ポリカーボネート、メタクリル樹脂、ポリメチルペンテン、ABS樹脂等、医療用材料として使用実績のあるものであれば特に限定されない。   Next, Embodiment 2 of the present invention will be described with reference to FIG. The second embodiment shown in FIG. 5 is a modification of the first embodiment. The flange 113 is formed separately from the male luer 111 and is fitted in the circumferential groove 117 on the outer surface of the male luer 111. Thereby, even when the flange is difficult to be integrally formed on the base portion of the male luer, the flange can be provided. As the forming material of the flange 113, polyolefin resin such as polyethylene, polypropylene, a mixture of polyethylene and polypropylene, and cyclic polyolefin is most preferable, but it has been used as a medical material such as polycarbonate, methacrylic resin, polymethylpentene, and ABS resin. If it is a thing, it will not specifically limit.

なお、フランジ113は別個に成形した後に周溝117に取りつけてもよいが、インサート成形により形成してもよい。   The flange 113 may be separately molded and then attached to the circumferential groove 117, but may be formed by insert molding.

次いで、本発明の実施例3を図6を用いて説明する。図6に示す実施例3は、実施例1のオネジ12とメネジ26を無くした構成よりなる。従ってフランジ213と爪部229の係合により、連通手段220と薬液容器210は接続されている。フラン213は、薬液容器210のオスルアー211の基部に、周方向全長にわたって径方向外側に突出するように一体成形されており、接続部225の基部の一部又は周方向全長にわたる部分からは爪部229が径方向内側に突設されており、フランジ213の基端面と係合している。なお、実施例3では、オスルアーと接続部を液密に接続するためのパッキン230をガイド部221の底面222とオスルアー225の先端面14との間に介装しておくことが好ましい。   Next, Embodiment 3 of the present invention will be described with reference to FIG. The third embodiment shown in FIG. 6 has a configuration in which the male screw 12 and the female screw 26 of the first embodiment are eliminated. Therefore, the communication means 220 and the chemical solution container 210 are connected by the engagement between the flange 213 and the claw portion 229. The furan 213 is integrally formed on the base of the male luer 211 of the chemical solution container 210 so as to protrude radially outward over the entire length in the circumferential direction, and a claw portion is formed from a part of the base of the connection portion 225 or a portion extending over the entire length in the circumferential direction. 229 protrudes radially inward and engages with the proximal end surface of the flange 213. In the third embodiment, it is preferable that a packing 230 for liquid-tightly connecting the male luer and the connection portion is interposed between the bottom surface 222 of the guide portion 221 and the front end surface 14 of the male luer 225.

次いで、本発明の実施例4を図7を用いて説明する。図7に示す実施例4は、実施例3の変形例で、フランジ313がオスルアー311とは別個に形成され、オスルアー311外面の周溝317に嵌合されている。これにより、フランジがオスルアーの基部に一体成形しにくい場合でも、フランジを設けることができる。フランジ313の形成材料としては、ポリエチレン、ポリプロピレン、ポリエチレンとポリプロピレンの混合物、環状ポリオレフィン等のポリオレフィン樹脂が最も好ましいが、ポリカーボネート、メタクリル樹脂、ポリメチルペンテン、ABS樹脂等、医療用材料として使用実績のあるものであれば特に限定されない。   Next, Embodiment 4 of the present invention will be described with reference to FIG. The fourth embodiment shown in FIG. 7 is a modification of the third embodiment, in which a flange 313 is formed separately from the male luer 311 and is fitted in a circumferential groove 317 on the outer surface of the male luer 311. Thereby, even when the flange is difficult to be integrally formed on the base portion of the male luer, the flange can be provided. As the material for forming the flange 313, polyethylene, polypropylene, a mixture of polyethylene and polypropylene, and polyolefin resins such as cyclic polyolefin are most preferable, but polycarbonate, methacrylic resin, polymethylpentene, ABS resin, etc. have been used as medical materials. If it is a thing, it will not specifically limit.

なお、フランジ313は別個に成形した後に周溝317に取りつけてもよいが、インサート成形により形成してもよい。   The flange 313 may be formed separately and then attached to the circumferential groove 317, but may be formed by insert molding.

また、図8に示す実施例5のように薬液容器410は、ポリエチレンやポリプロピレン等の可撓性材料で形成された、押圧により容易に変形可能なボトル415であってもよい。   Further, as in Example 5 shown in FIG. 8, the chemical solution container 410 may be a bottle 415 that is formed of a flexible material such as polyethylene or polypropylene and can be easily deformed by pressing.

本発明の実施利1の縦断面図である。It is a longitudinal cross-sectional view of Example 1 of this invention. 本発明の実施例1の拡大断面図である。It is an expanded sectional view of Example 1 of the present invention. 本発明の実施例1の拡大正面図である。It is an enlarged front view of Example 1 of the present invention. 本発明の実施例1の拡大正面図である。It is an enlarged front view of Example 1 of the present invention. 本発明の実施例2を示す拡大断面図である。It is an expanded sectional view which shows Example 2 of this invention. 本発明の実施例3を示す拡大断面図である。It is an expanded sectional view showing Example 3 of the present invention. 本発明の実施例4を示す拡大断面図である。It is an expanded sectional view showing Example 4 of the present invention. 本発明の実施例5を示す縦断面図である。It is a longitudinal cross-sectional view which shows Example 5 of this invention. 本発明の使用状況を示す図である。It is a figure which shows the use condition of this invention.

符号の説明Explanation of symbols

1 連通手段付き薬液容器
10、110、310 薬液容器
11、111、211、311 オスルアー
13、113、213、313 フランジ
14、214 先端面
15 バレル
20、220 連通手段
21、221 ガイド部
22、222 底面
23 穿刺部材
24 穿刺針
25、225 接続部
26、41 メネジ
27 破断部
28 残留部
30、230 パッキン
40 ガスケット
415 ボトル
S 薬液
1 Chemical solution container with communication means 10, 110, 310 Chemical solution container 11, 111, 211, 311 Oscillator 13, 113, 213, 313 Flange 14, 214 Tip surface 15 Barrel 20, 220 Communication means 21, 221 Guide portion 22, 222 Bottom surface DESCRIPTION OF SYMBOLS 23 Puncture member 24 Puncture needle 25,225 Connection part 26,41 Female screw 27 Breaking part 28 Residual part 30,230 Packing 40 Gasket 415 Bottle S Chemical solution

Claims (6)

注射針を接続可能なオスルアーを先端に有する薬液容器と、前記オスルアーの先端に設けられた中空の連通手段を含み、該連通手段は、バイアルの口部をスライド自在に挿着可能な有底筒状のガイド部と、該ガイド部の底面中央部に該底面を貫通して設けられた中空の穿刺部材を含み、該穿刺部材は、底面より先端側の穿刺針と底面より基端側の接続部を有し、該接続部が前記オスルアーに螺合により接続されてなる連通手段付き薬液容器であって、
前記接続部のメネジよりも基端側に、破断部を介して残留部が連接され、前記残留部が前記オスルアー基部のフランジに係合され、前記接続部と前記オスルアーの螺合の解除時に前記破断部が破断する薬液容器。
A liquid container having a male luer that can be connected to an injection needle at the tip, and a hollow communication means provided at the tip of the male luer, the communication means being a bottomed tube in which the mouth of the vial can be slidably inserted And a hollow puncture member provided through the bottom surface at the center of the bottom surface of the guide portion, the puncture member being connected to the puncture needle on the distal end side from the bottom surface and the proximal end side from the bottom surface A chemical container with communication means, wherein the connecting portion is connected to the male luer by screwing,
A residual portion is connected to the base end side of the female screw of the connection portion via a fracture portion, the residual portion is engaged with a flange of the male luer base portion, and when the screwing of the connection portion and the male luer is released, A chemical container in which the fracture part breaks.
先端にオスルアーを有する薬液容器と、前記オスルアーの先端に設けられた中空の連通手段を含み、該連通手段は、バイアルの口部をスライド自在に挿着可能な有底筒状のガイド部と、該ガイド部の底面中央部に該底面を貫通して設けられた中空の穿刺部材を含み、該穿刺部材は、底面より先端側の穿刺針と底面より基端側の接続部を有し、該接続部が前記オスルアーに係合により接続されてなる連通手段付き薬液容器であって、
前記接続部の基部に破断部を介して残留部が連接され、前記残留部が前記オスルアー基部のフランジに係合されることで前記接続部が前記オスルアーに接続され、前記接続部と前記オスルアーの分離時に前記破断部が破断する薬液容器。
Including a chemical container having a male luer at the tip, and a hollow communication means provided at the tip of the male luer, the communication means having a bottomed cylindrical guide that can be slidably inserted into the mouth of the vial; A hollow puncture member provided through the bottom surface at the center of the bottom surface of the guide portion, the puncture member having a puncture needle closer to the distal end than the bottom surface and a connection portion closer to the proximal end than the bottom surface; A chemical solution container with communication means, wherein the connecting portion is connected to the male luer by engagement,
The residual portion is connected to the base portion of the connection portion via a fracture portion, and the connection portion is connected to the male luer by engaging the residual portion with a flange of the male luer base portion. A chemical container in which the rupture portion breaks during separation.
前記ガイド部の底面とオスルアーの先端面との間に、同心円状のパッキンを介装してなる請求項1又は2に記載の薬液容器。   The chemical | medical solution container of Claim 1 or 2 formed by interposing a concentric packing between the bottom face of the said guide part and the front end surface of a male lure. 前記薬液容器が、先端にオスルアーを有する基端の開放されたバレルと、該バレルの基端からバレル内に液密かつ摺動可能に挿着されたガスケットからなるシリンジである請求項1〜3の何れかに記載の薬液容器。   4. A syringe comprising a barrel having an open end with a male luer at a distal end and a gasket that is liquid-tightly and slidably inserted into the barrel from the proximal end of the barrel. The chemical | medical solution container in any one of. 前記薬液容器が、先端にオスルアーを有する、押圧により容易に変形可能なボトルである請求項1〜3の何れかに記載の薬液容器。   The chemical solution container according to any one of claims 1 to 3, wherein the chemical solution container is a bottle that has a male luer at a tip and can be easily deformed by pressing. 内部に予め薬液が充填されてなる請求項1〜5の何れかに記載の薬液容器。
The chemical solution container according to any one of claims 1 to 5, wherein the chemical solution is previously filled therein.
JP2003383224A 2003-11-13 2003-11-13 Medical fluid container equipped with communication means Pending JP2005143677A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003383224A JP2005143677A (en) 2003-11-13 2003-11-13 Medical fluid container equipped with communication means

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003383224A JP2005143677A (en) 2003-11-13 2003-11-13 Medical fluid container equipped with communication means

Publications (2)

Publication Number Publication Date
JP2005143677A true JP2005143677A (en) 2005-06-09
JP2005143677A5 JP2005143677A5 (en) 2006-07-27

Family

ID=34692007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003383224A Pending JP2005143677A (en) 2003-11-13 2003-11-13 Medical fluid container equipped with communication means

Country Status (1)

Country Link
JP (1) JP2005143677A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012128115A1 (en) * 2011-03-18 2012-09-27 テルモ株式会社 Integrated puncture needle adapter
JP2015142794A (en) * 2006-12-08 2015-08-06 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Method and apparatus for delivering therapeutic substance through injection port
FR3031668A1 (en) * 2015-01-20 2016-07-22 Philippe Perovitch DEVICE FOR DELIVERY OF ACTIVE PRINCIPLE BY PERMUCOSAL MOUTH.
US20200030552A1 (en) * 2017-04-04 2020-01-30 Nipro Corporation Syringe type ejection device
CN114206295A (en) * 2019-07-03 2022-03-18 贝克顿·迪金森公司 Medical device, medical device assembly comprising the medical device and method of reconstituting a pharmaceutical composition

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015142794A (en) * 2006-12-08 2015-08-06 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Method and apparatus for delivering therapeutic substance through injection port
US10549049B2 (en) 2006-12-08 2020-02-04 Becton, Dickinson And Company Method and apparatus for delivering a therapeutic substance through an injection port
KR101939858B1 (en) * 2011-03-18 2019-01-17 테루모 가부시키가이샤 Integrated puncture needle adapter
CN103429215A (en) * 2011-03-18 2013-12-04 泰尔茂株式会社 Integrated puncture needle adapter
US20140005598A1 (en) * 2011-03-18 2014-01-02 Terumo Kabushiki Kaisha Integrated puncture needle adapter
KR20140006950A (en) * 2011-03-18 2014-01-16 테루모 가부시키가이샤 Integrated puncture needle adapter
EP2687199A1 (en) * 2011-03-18 2014-01-22 Terumo Kabushiki Kaisha Integrated puncture needle adapter
EP2687199A4 (en) * 2011-03-18 2014-01-22 Terumo Corp Integrated puncture needle adapter
US9387150B2 (en) * 2011-03-18 2016-07-12 Terumo Kabushiki Kaisha Integrated puncture needle adapter
WO2012128115A1 (en) * 2011-03-18 2012-09-27 テルモ株式会社 Integrated puncture needle adapter
JP5977734B2 (en) * 2011-03-18 2016-08-24 テルモ株式会社 Puncture needle integrated adapter and method of using the puncture needle integrated adapter
FR3031668A1 (en) * 2015-01-20 2016-07-22 Philippe Perovitch DEVICE FOR DELIVERY OF ACTIVE PRINCIPLE BY PERMUCOSAL MOUTH.
WO2016116693A1 (en) 2015-01-20 2016-07-28 Maury, Marc Device for administering an active principle by the oral mucosal route
US20200030552A1 (en) * 2017-04-04 2020-01-30 Nipro Corporation Syringe type ejection device
US11638791B2 (en) * 2017-04-04 2023-05-02 Nipro Corporation Syringe type ejection device
CN114206295A (en) * 2019-07-03 2022-03-18 贝克顿·迪金森公司 Medical device, medical device assembly comprising the medical device and method of reconstituting a pharmaceutical composition
JP2022539251A (en) * 2019-07-03 2022-09-07 ベクトン・ディキンソン・アンド・カンパニー Medical devices, medical device assemblies containing same, and methods of reconstituting pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP4427965B2 (en) Chemical container with communication means
JP3763141B2 (en) Syringe type chemical container
JP4682850B2 (en) Prefilled syringe
US7736353B2 (en) Pharmaceutical delivery systems and methods for using same
US3796218A (en) Syringe adaptor for use with a wet/dry mixing vial
JP2007185319A5 (en)
JPH0380029B2 (en)
JPH1057503A (en) Fluid transfer device for accessing fluid from vial and ampoule, and fluid transfer method using the device
CN112105328B (en) Connector for connecting a medical injection device to a container
US10525212B2 (en) Single use injector
US20080188807A1 (en) Syringe Assembly Having Re-Use Prevention Features
JP4579486B2 (en) Prefilled syringe kit
JP2005143677A (en) Medical fluid container equipped with communication means
US20210252226A1 (en) Pharmaceutical Product Preparation Device and Method
JP2004105234A (en) Pre-filled syringe kit
JP4110569B2 (en) Prefilled syringe kit
JP2004097583A (en) Two-component mixing type pre-filled syringe
JP4158446B2 (en) Filled bellows container
JP2004049803A (en) Two component mixing type pre-filled syringe
JP4114197B2 (en) Prefilled syringe kit
JP2004097472A (en) Two component mixed type pre-filled syringe

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060613

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060613

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090303

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090305

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090630